Tests brain stimulation over the cerebellum in adults with autism
Tests magnetic brain stimulation over the cerebellum in adults with autism spectrum disorder.
Plain-language title generated from the registry record
Registry title: Explore the Impacts of One Session and Multiple Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder
Key facts
- Where
- Taoyuan, TaiwanSee the site
Where in Taiwan
- Chang Gung Memorial HospitalTaoyuan, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chang Gung Memorial Hospital
- Trial code
- NCT07114770
- Record updated
- 11 August 2025
- Original description
This study aims to establish a personalized theta burst stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation, rTMS) protocol considering autistic idiosyncrasy (interindividual variability).Read full original descriptionShow less
Explore the Impacts of One Session and Multiple Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder
This study aims to establish a personalized theta burst stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation, rTMS) protocol considering autistic idiosyncrasy (interindividual variability).
Inclusion: Autistic adults (≥18 years old), confirmed by Autism Diagnostic Observation Schedule; DSM-5 severity level of ASD: level 1 or level 2; ≥18 years old without autism spectrum disorder.
Exclusion: Previous or current severe neurological disorders, especially epilepsy; Previous or current severe systemic diseases such as cardiovascular disease, diabetes or hypertension; Previous or current severe brain injury; Implementation of metal materials such as a pacemaker or medication pump; Previous or current severe psychiatric disorders such as schizophrenia, bipolar disorder, severe major depressive disorder or substance abuse; Previous brain surgery or central nerve system infection; Concurrent use of medications which increased the risk of seizure attack; Concurrent use of antiepileptic drugs; Start to use antiepileptic drugs during study period; Have experienced sleep disorders during brain stimulation; Seizure attack during the study period; Pregnancy; Intracranial space occupied lesions; Participate in another clinical trial within one month; With damaged skin at the stimulated region; With multiple sclerosis; With large ischemic scars; Severe alcoholism; Uncontrollable migraines due to increased intracranial pressure; Unsuitable for MRI (e.g. those with claustrophobia); Unsuitable for EEG; DSM-5 severity level of ASD: level 3; Suicidal ideation within one year; Withdrawal criteria:; Autistic symptoms worsened obviously during the study period (change of DSM-5 severity level); Extreme agitation or irritability during the study period; Participants request; Clinical symptoms worsened obviously during study period; Suicidal ideation or self-harm behaviors during study period.